Manufacturing Industry

Ondine Biopharma, Henry Schein enter into agreement.

PR Newswire UK Disclose, December, 2004

    Ondine Biopharma and Henry Schein enter into strategic distribution 
 
    agreement 
 
 
 
    VANCOUVER, Dec. 13 /CNW/ - Ondine Biopharma Corporation (TSX-V:OBP, 
 
AIM: OBP) ("Ondine") announced today that a strategic agreement in which 
 
Henry Schein (Nasdaq: HSIC), the largest distributor of healthcare products 
 
and services to office-based practitioners in the combined North American and 
 
European markets, will become the exclusive distributor of dental products 
 
utilizing Ondine's innovative, patented platform technology, PhotoDynamic 
 
Disinfection (PDD). 
 
    Under this agreement, Henry Schein will be the exclusive distributor for 
 
PhotocideX, a product requiring approval by the U.S. Food and Drug 
 
Administration (FDA) and the first product from the PDD...

            
        
    
    	    
                
                
	
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
  • Click Here
advertisement